Web Analytics
Cổ phiếu REPL (NASDAQ) | REPLIMUNE GROUP INC – Phân tích Deepscope
MARKET

Select Market Data Region

REPL — REPLIMUNE GROUP INC (Healthcare >> Biotechnology)

REPL FAQ

What is REPL's ROE?

REPLIMUNE GROUP INC reports a Return on Equity (ROE) of -149.55%.

What is REPL's dividend yield?

REPLIMUNE GROUP INC offers a dividend yield of 0.00%.

What is REPL's Deepscope Quality Score?

Deepscope rates REPL's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy REPL?

Deepscope's AI Timing Score for REPL is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does REPL belong to?

REPLIMUNE GROUP INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-05 | FS: 2025-12-31)

REPL

REPLIMUNE GROUP INC
USD 9.47
-0.40 (-4.05%) Day Change
0.25
D/E
-149.6%
ROE
-94.4%
ROA
0.00%
Div Yield
USD 9.47
Price
-0.40 (-4.05%)
Day Change
NEWS SCORE: 43

REPL Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 31) nhưng Thời điểm mua ...(Sign In to See)...

31

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng 45%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 43
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 9.47
  PBV / Sector
3.87 / 4.63
  Earning Per Share -3.66
  PE / Sector
N/A / 17.43
  PEG or PE/Growth / Sector
N/A / 0.53
  Average 1M Daily Value
62.28 M
  Average 1W Daily Value
71.26 M
Yếu tố Kỹ thuật 71%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Sức khỏe tài chính 50%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Khả năng kiếm lợi nhuận 43%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
-21,389.47 / 449.48
  NPM Average (%) / Sector
-21,389.47 / -1,506.49
  NPM Change Average (%) / Sector
N/A / 4,940.99
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-94.38 / 30.58
  ROA Average (%) / Sector
-47.21 / -347.17
  ROA Change Average (%) / Sector
45.32 / 5,125.52
GREAT
  ROE (%) / Sector
-149.55 / -3.58
  ROE Average (%) / Sector
-65.35 / 40.65
  ROE Change Average (%) / Sector
61.90 / 2,109.80
GREAT
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Lợi tức cho nhà đầu tư 4%
X
  Dividend (%) / Sector
N/A / 0.05
  Dividend Average (%) / Sector
N/A / 16.49
  Dividend Change Average (%) / Sector
N/A / 4.17
Chi tiết đăng ký
X
  Analyze Date 2026-06-06 09:08:26
  Symbol REPL
  Name REPLIMUNE GROUP INC
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 82.57 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 814.99 / 8,857.28
Tin tức, Dự báo ước tính
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 500 Unicorn Park Drive, Woburn, MA, United States, 01801

Phone: 781 222 9600

Website: https://www.replimune.com

Employees: 479

Sector: Healthcare >> Biotechnology

Description: Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company's proprietary oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors. The company is also developing RP2 that express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3, which express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.

ME vs SECTOR Healthcare >> Biotechnology

REPL (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
REPL
REPL
USD 9.47 (-4.05%)
+ Watch + Port Chart